Primary Cells

Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)

  • For research use only

Cat No.

ABC-TC3889

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Cell Type

Mononuclear Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Mantle Cell Lymphoma

Storage

Liquid Nitrogen

Human Mantle Cell Lymphoma PBMCs (Newly Diagnosed/Untreated) support lymphoma immunology, biomarkers, and therapy evaluation in patient samples. in lab.

Product Image

Description

Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated) are derived from the peripheral blood of patients with newly diagnosed mantle cell lymphoma (MCL) who have not received any treatment. These cells are often characterized by t(11;14)(q13;q32) translocation leading to cyclin D1 overexpression. They contain malignant transformed cells of B-cell non-Hodgkin’s lymphoma, and show high expression of CD20, CD5, cyclin D1 (CCND1), SOX11. Morphologically, these cells usually appear as lymphocytes with medium sized, irregular nuclei and condensed chromatin, and some of them can be seen as “blastoid” variants, showing invasive growth characteristics. Their functional abnormalities are manifested as enhanced anti-apoptosis ability, dysregulated proliferation and immune escape. In translational and clinical studies, these samples are widely used to analyze gene expression profiles, investigate disease progression and immune responses, and evaluate emerging therapeutic strategies in mantle cell lymphoma.

Species

Human

Cat.No

ABC-TC3889

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Mantle Cell Lymphoma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated) can be used as an in vitro cell model to study the pathogenesis of mantle cell lymphoma (MCL), such as dysregulated proliferation, apoptosis resistance and signaling pathway abnormalities (including BCR, NF-κB and PI3K pathways) of MCL. These cells can also be used to evaluate the efficacy and resistance mechanism of targeted drugs such as BTK inhibitors (such as ibrutinib) and BCL-2 inhibitors (such as venetoclax).

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button